I started writing commentary articles on X this week. The first one is a riff on Sequoia’s “Services: The New Software” piece, examining what their thesis means for regulated industries like pharma. Read it here: x.com/BioInfo/status/20…

Quick context on why three outlets:

Run Data Run (Substack) is the long-form stuff. Thought leadership, essays, the pieces I spend a week on. Business leaders and motivated learners. That’s not changing.

AIXplore (ai.rundatarun.io) is the technical blog. Deep dives for AI practitioners and builders. Also not changing.

X Articles are the new addition. Shorter, faster commentary on things happening right now. A Sequoia piece drops, an interesting paper comes out, a vendor makes a move. I write a take the same day. More reactive, still substantive.

Different audiences, different cadences. Not trying to duplicate anything across the three.

If you want the commentary pieces, follow me on X/Twitter (@BioInfo). Substack and AIXplore subscribers, nothing changes for you.

First article: what happens when AI lets you sell the work instead of the tool, and why the $6 trillion services market is about to compress.

hashtag#AIStrategy hashtag#ContentStrategy